天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 241479-67-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 241479-67-4
Chemical Structure| 241479-67-4
Structure of 241479-67-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 241479-67-4 ]

Related Doc. of [ 241479-67-4 ]

Alternatived Products of [ 241479-67-4 ]
Product Citations

Product Details of [ 241479-67-4 ]

CAS No. :241479-67-4 MDL No. :
Formula : C22H17F2N5OS Boiling Point : -
Linear Structure Formula :- InChI Key :DDFOUSQFMYRUQK-RCDICMHDSA-N
M.W : 437.47 Pubchem ID :6918485
Synonyms :
BAL-4815;RO-0094815;trade name Cresemba.;BAL-8557-002
Chemical Name :4-[2-[(1R,2R)-2-(2,5-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile

Calculated chemistry of [ 241479-67-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 31
Num. arom. heavy atoms : 22
Fraction Csp3 : 0.18
Num. rotatable bonds : 6
Num. H-bond acceptors : 7.0
Num. H-bond donors : 1.0
Molar Refractivity : 111.46
TPSA : 115.86 ?2

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.46 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.26
Log Po/w (XLOGP3) : 3.54
Log Po/w (WLOGP) : 4.97
Log Po/w (MLOGP) : 2.46
Log Po/w (SILICOS-IT) : 5.2
Consensus Log Po/w : 3.89

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.91
Solubility : 0.00536 mg/ml ; 0.0000123 mol/l
Class : Moderately soluble
Log S (Ali) : -5.66
Solubility : 0.000962 mg/ml ; 0.0000022 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.33
Solubility : 0.0000204 mg/ml ; 0.0000000466 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.26

Safety of [ 241479-67-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 241479-67-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 241479-67-4 ]

[ 241479-67-4 ] Synthesis Path-Downstream   1~11

  • 1
  • [ 186353-05-9 ]
  • [ 241479-67-4 ]
  • [[N-methyl-N-phenyl]carbamoyloxy]methyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium chloride [ No CAS ]
  • 2
  • acetic acid 2-(iodomethoxycarbonyl-methyl-amino)-ethyl ester [ No CAS ]
  • [ 241479-67-4 ]
  • [[N-methyl-N-2-(acetoxy)ethyl]carbamoyloxy]methyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium iodide [ No CAS ]
  • 3
  • [N-methyl-N-3-(acetoxy)propyl]carbamic acid chloromethyl ester [ No CAS ]
  • [ 241479-67-4 ]
  • [[N-methyl-N-3-(acetoxy)propyl]carbamoyloxy]methyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium iodide [ No CAS ]
  • 4
  • [ 338990-23-1 ]
  • [ 241479-67-4 ]
  • [[2(S)-(acetoxymethyl)pyrrolidin-1-yl]carbonyloxy]methyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium iodide [ No CAS ]
  • 5
  • [ 338990-20-8 ]
  • [ 241479-67-4 ]
  • [[N-methyl-N-2-(acetoxymethyl)phenyl]carbamoyloxy]methyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium chloride [ No CAS ]
YieldReaction ConditionsOperation in experiment
63% sodium iodide; In acetonitrile; at 20 - 80℃; for 9h; A solution of 1-[3-[4-(4-cyano-phenyl)-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxy-butyl-1H-[1,2,4]triazol (200 mg, 0.457 mmol), sodium iodide (6.8 mg 0.045 mmol) and acetic acid 2-(chloromethoxycarbonyl-methyl-amino)-benzyl ester 150 mg, 0.552 mmol) was stirred for 6 h at ambient temperature and then at 80° C. for 3 h under Ar atmosphere. The reaction mixture was concentrated under reduced pressure and the resulting material was eluted on a column of silica gel (Kusano Si-5, eluent dichloromethane:methanol=20:1). The fractions containing the product were concentrated under reduced pressure giving the title compound a) as colorless amorphous (204.5 mg, 63percent). 1H-NMR (270 MHz, DMSO-d6): delta 1.20 (3H, d, J=6.9), 1.99 (3H, s), 3.12 (2.4H, s), 3.15 (0.6H, s), 4.15 (1H, q, J=7.3), 4.79-4.91 (3H, m), 5.09 (1H, d, J=14.8), 5.76 (1H, s), 5.90-6.10 (1.6H, m), 6.17 (0.4H, br.s), 6.61-6.66 (1H, m), 7.05-7.15 (1H, m), 7.26-7.44 (6H, m), 7.91-7.96 (2H, m), 8.20-8.24 (2H, m),8.49 (1H, s), 9.01 (0.8H, br.d, J=3.6), 9.12 (0.2H, br.s), 10.16 (0.8H, br.d, J=4.9), 10.27 (0.2H, br.s); FAB-MS: 673 (M-Cl)+; Ratio of Retention Time in HPLC: 1.79 (see Example D).
  • 6
  • [ 338990-31-1 ]
  • [ 241479-67-4 ]
  • 1-[[N-methyl-N-3-[(t-butoxycarbonylmethylamino)acetoxymethyl]pyridin-2-yl]carbamoyloxy]ethyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium chloride [ No CAS ]
  • 7
  • [ 338990-41-3 ]
  • [ 241479-67-4 ]
  • 4-[1-({2-[(<i>tert</i>-butoxycarbonyl-methyl-amino)-acetoxymethyl]-5-chloro-phenyl}-methyl-carbamoyloxy)-ethyl]-1-[3-[4-(4-cyano-phenyl)-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxy-butyl]-1<i>H</i>-[1,2,4]triazol-4-ium; chloride [ No CAS ]
  • 8
  • [ 338990-44-6 ]
  • [ 241479-67-4 ]
  • 4-[1-({2-[(<i>tert</i>-butoxycarbonyl-methyl-amino)-acetoxymethyl]-3-fluoro-phenyl}-methyl-carbamoyloxy)-ethyl]-1-[3-[4-(4-cyano-phenyl)-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxy-butyl]-1<i>H</i>-[1,2,4]triazol-4-ium; chloride [ No CAS ]
  • 9
  • [ 338990-35-5 ]
  • [ 241479-67-4 ]
  • 4-[1-({2-[(<i>tert</i>-butoxycarbonyl-methyl-amino)-acetoxymethyl]-4-fluoro-phenyl}-methyl-carbamoyloxy)-ethyl]-1-[3-[4-(4-cyano-phenyl)-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxy-butyl]-1<i>H</i>-[1,2,4]triazol-4-ium; chloride [ No CAS ]
  • 10
  • [ 338990-34-4 ]
  • [ 241479-67-4 ]
  • 4-[1-({2-[(<i>tert</i>-butoxycarbonyl-methyl-amino)-acetoxymethyl]-4,5-difluoro-phenyl}-methyl-carbamoyloxy)-ethyl]-1-[3-[4-(4-cyano-phenyl)-thiazol-2-yl]-2-(2,5-difluoro-phenyl)-2-hydroxy-butyl]-1<i>H</i>-[1,2,4]triazol-4-ium; chloride [ No CAS ]
  • 11
  • [ 338990-27-5 ]
  • [ 241479-67-4 ]
  • [ 338990-62-8 ]
YieldReaction ConditionsOperation in experiment
51% sodium iodide; In acetonitrile; at 70℃; To a solution of [N-methyl-N-2-((tert-butoxycarbonylisopropylamino)methyl)phenyl]carbamic acid 1-chloro-ethyl ester (143 mg, 0.342 mmol) in acetonitrile (1 ml) was added the azole compound (163 mg, 0.372 mmol) and catalytic amount of sodium iodide at 70° C. After stirring overnight, the solvent was removed and extracted with ethyl acetate. The organic phase was washed with water and brine. The solvent was removed in vacuo. The residue was purified by column chromatography (ethyl acetate to 10percent methanel-dichloromethane) to afford 1-[[N-methyl-N-2-(t-butoxycarbonyl-isopropylaminomethyl)phenyl]carbamoyloxy]ethyl-1-[(2R,3R)-2-(2,5-difluorophenyl)-2-hydroxy-3-[4-(4-cyano-phenyl)thiazol-2-yl]butyl]-1H-[1,2,4]triazol-4-ium chloride (155 mg, 0.189 mmol, 51percent) as off-white amorphous.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;